- Home
- MSC vs KZIA Comparison
MSC vs KZIA Comparison
Compare MSC & KZIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MSC | KZIA |
|---|---|---|
| Founded | 2000 | 1994 |
| Country | Hong Kong | Australia |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 188.9M | 186.7M |
| IPO Year | 2017 | 2002 |
Fundamental Metrics
Financial Performance| Metric | MSC | KZIA |
|---|---|---|
| Price | $0.96 | $8.89 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $28.36 |
| AVG Volume (30 Days) | 185.8K | ★ 277.8K |
| Earning Date | 11-05-2026 | 11-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.77 | $4.86 |
| 52 Week High | $4.69 | $17.40 |
Technical Indicators
Market Signals| Indicator | MSC | KZIA |
|---|---|---|
| Relative Strength Index (RSI) | 37.20 | 32.99 |
| Support Level | $0.77 | $5.15 |
| Resistance Level | $1.11 | $14.85 |
| Average True Range (ATR) | 0.12 | 0.64 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 61.78 | 7.47 |
Price Performance
Historical ComparisonAbout MSC Studio City International Holdings Limited
Studio City International Holdings Ltd is a gaming, retail, and entertainment resort located in Cotai, Macau. It operates Studio City Casino with around 250 mass-market gaming tables; including tables for VIP rolling chip operations, and 552 gaming machines. Studio City features luxury hotel rooms, diverse food and beverage establishments, and complementary retail space. In addition, the company offers non-gaming attractions, including the world's first figure-8 Ferris wheel, a deluxe nightclub and karaoke venue, a live performance arena, an outdoor and an indoor water park. Geographically, the company derives the majority of its revenue from the Macau region.
About KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is a biotechnology company focused on pharmaceutical drug development in oncology. The company has a portfolio of development candidates across various technologies targeting multiple cancer indications. Its primary program is Paxalisib, an investigational brain-penetrant inhibitor of the PI3K/Akt/mTOR pathway, designed for the treatment of brain cancer. The company develops targeted therapies aimed at addressing medical needs in oncology. The company operates in Australia and the United States.